Table S3.
Perioperative changes in patients with HBV-related HCC
| Index | Preoperative levels
|
P-value | Postoperative levels
|
P-value | ||
|---|---|---|---|---|---|---|
| PHR (n=50) | Non-PHR (n=208) | PHR (n=50) | Non-PHR (n=208) | |||
| PT (seconds) | 13.51±1.64 | 12.73±1.41 | 0.876 | 13.91±1.57 | 13.61±1.67 | 0.821 |
| TBil (μmol/L) | 13.00 (6.50–16.70) | 10.10 (4.50–14.20) | 0.264 | 18.90 (11.30–22.50) | 17.60 (9.80–20.60) | 0.862 |
| ALB (g/L) | 36.01±2.27 | 41.32±4.79 | 0.001 | 31.75±5.79 | 36.10±4.26 | 0.032 |
| ALT (IU/L) | 38.30 (22.30–46.50) | 34.10 (20.10–42.90) | 0.291 | 130.50 (79.00–282.30) | 115.20 (75.00–210.60) | 0.086 |
| AFP (ng/mL) | 616.20 (8.00–12,100.00) | 125.00 (6.50–12,100.00) | 0.101 | 352.50 (6.30–4,940.00) | 106.50 (4.50–3,630.00) | 0.063 |
| CD3+CD4+ (%) | 31.17±8.83 | 38.46±8.71 | 0.041 | 18.94±7.14 | 39.97±11.02 | <0.001 |
| CD3+CD8+ (%) | 21.34±7.28 | 22.39±7.55 | 0.621 | 13.74±5.49 | 25.43±7.46 | <0.001 |
Note: Values are shown as mean ± SD, n (%), or average (range), unless otherwise indicated.
Abbreviations: AFP, α-fetoprotein; ALB, albumin; ALT, alanine aminotransferase; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; PHR, postoperative HBV reactivation; PT, prothrombin time; TBil, total bilirubin.